Depending on the country a prescription may be required
Researched applications In the published preclinical and clinical literature the effects of Cagrilintide are documented in the following areas: Obesity (stand-alone) , Phase 2 data (Lau 2021, 10.8 % at 4.5 mg) Obesity + Semaglutide (CagriSema) , Phase 3 REDEFINE 1 (25.3 %) T2DM + obesity , Phase 3 REDEFINE 2 Cardiovascular prevention , Phase 3 REDEFINE 3 (n ~ 7000) MASLD/MASH , exploratory in Phase 2 Type 2 diabetes (monotherapy) , preclinical data Prediabetes , exploratory plans Science & studies 4.1 Key publications Lau D.C.W., Erichsen L., Francisco A.M., et al
Unlike standalone peptide therapies, this stack delivers: Baseline GH elevation from CJC-1295 Pulsatile GH spikes from Ipamorelin A natural mimicking of endogenous GH secretion , which supports lean muscle mass, fat loss, improved sleep, skin health, and faster recovery Whether you're a seasoned athlete looking for recovery support or someone trying to slow the aging process with a safer alternative to HGH, this combo offers clinical-level benefits without the clinical-level drawbacks
Patients at Endocrinology Associates who ask about peptide treatment often have specific goals: healing after an injury, training for an event, or staying active without relying on medication
